Log inSign up

Ambagon Therapeutics

0 followers

‌

Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.

Industries

Analytics, Biotechnology

Headquarters

San Francisco, United States

Employees

11-50

Links

Org chart

Willem van den Hout
Research Associate, Biochemistry
Rens de Vries
Scientist, Structural Biology
Ceri Zwart
Associate Scientist
ES
Eline Sijbesma
Scientist
Galen Miley
Senior Scientist
Karolina Kaminska
Associate Scientist
Laura Demmers
Senior Scientist
Tom van de Wijngaart
Research Associate, Structural Biology
Loes Stevers
Principal Scientist Biochemistry
Paul Hollenbach
Scientist
Donna Olivia Debets
Senior Scientist Proteomics
Michelle Pazmino
Senior Research Associate
Taggra Jackson
Sr. Research Associate
Tanja Meyer
VP & Head, Corporate Strategy & Business Development

Teams

+12

Scientific Research Team

15 members

AR
+4

Directors Team

7 members

AA
CB
+4

Scientific Advisory Team

7 members

Leadership Team

1 members

Similar companies

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Apogee Therapeutics

1 follower

Othram

1 follower

Gridware

2 followers

eGenesis

1 follower

Prepared

1 follower

Thermo Fisher Scientific

168 followers

Genentech

150 followers

Explore companies